Ambulatory monitoring of cumulative free-living activity has enormous potential clinical applicability in the care and clinical trials of patients with COPD.
Should not yet alter COPD care or trial endpoints; leaves open the role of activity monitoring pending prospective validation.
Discusses potential clinical applications of monitoring patients with chronic obstructive pulmonary disease (COPD). It is concluded that the ability to measure cumulative free-living activity in patients with COPD appears to have enormous potential clinical applicability. Ongoing research to develop unobtrusive, wearable sensors that extend monitoring periods and couple these data with wireless technology is needed. Research studies are also needed to assess the role measurement of cumulative free-living activity plays in both the clinical care of patients with COPD and clinical trials involving COPD, therapeutics. It may prove to be optimally used alone or in conjunction with existing measures of clinical status.
No takes yet. Share an insight, caveat, or question.
Moy et al. (2003) studied this question.